S. 207 · 115th Congress
SALTS Act
- Stage
- Reported from committee
- Sponsor
- Amy Klobuchar
- Introduced
- 2017-01-24
- Latest action
- 2018-06-19 · Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.
Summary
Synthetic Abuse and Labeling of Toxic Substances Act of 2017 or the SALTS Act
(Sec. 2) This bill amends the Controlled Substances Act to set forth factors that may be considered as evidence to determine whether a controlled substance analogue is intended for human consumption. (Under current law, a controlled substance analogue that is intended for human consumption is treated as a schedule I controlled substance. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)